Evidence map›Paper›PMID 36354869›Full record

ArticleJournal of imaging2022

Iodine-123 β-methyl-P-iodophenyl-pentadecanoic Acid (

Yuko Harada, Kyosuke Shimada, Satoshi John Harada, Tomomi Sato, Yukino Kubota, Miyoko Yamashita

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yuko HaradaDepartment of Cardiology, Kawasaki Municipal Ida Hospital, Kawasaki 211-0035, Japan.
Kyosuke ShimadaDepartment of Breast Surgery, Kawasaki Municipal Ida Hospital, Kawasaki 211-0035, Japan.
Satoshi John HaradaUniversity School of Medicine, Shinanomachi Campus, Tokyo 160-8582, Japan.
Tomomi SatoDepartment of Breast Surgery, Kawasaki Municipal Ida Hospital, Kawasaki 211-0035, Japan.
Yukino KubotaDepartment of Palliative Care Medicine, Kawasaki Municipal Ida Hospital, Kawasaki 211-0035, Japan.
Miyoko YamashitaDepartment of Radiology, Kawasaki Municipal Ida Hospital, Kawasaki 211-0035, Japan.
Kawasaki Municipal Hospital · JPKeio University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The mortality of breast cancer has decreased due to the advancement of cancer therapies. However, more patients are suffering from cancer-therapeutics-related cardiac dysfunction (CTRCD). Diagnostic and treatment guidelines for CTRCD have not been fully established yet. Ultrasound cardiogram (UCG) is the gold standard for diagnosis of CTRCD, but many breast cancer patients cannot undergo UCG due to the surgery wounds or anatomical reasons. The purpose of the study is to evaluate the usefulness of myocardial scintigraphy using Iodine-123 β-methyl-P-iodophenyl-pentadecanoic acid (

Indexed as

123I-BMIPPbreast cancerchemotherapy-related cardiac dysfunction (CTRCD)echocardiographymyocardial scintigraphy

Identifiers

PMID36354869
PMCPMC9695533
OpenAlexW4307764985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.